Danish Logistics Stock News

Carlsberg (CPSE:CARL B) has given investors fresh numbers to assess after reporting half year 2026 results, with sales of DKK 47,053 million and net income of DKK 3,801 million. See our latest analysis for Carlsberg. Carlsberg’s share price is DKK 881.6 after a 2.04% 1 day share price gain, although the 30 day share price return is down 6.01%. Over the past year, total shareholder return is 17.06%, while the 3 year and 5 year total shareholder returns show small declines. This suggests...

Shipping routes are being rewritten in real time as the Panama Canal cuts daily ship transits and trade frictions shift between major economies. That disruption can reshuffle pricing power and cargo volumes, which means some globally exposed stocks may gain fresh momentum while others struggle to adjust. This article walks through three stocks from a Global Shipping and Logistics Beneficiaries screener and explains how each is positioned in this new trade reality. The three stocks covered...

Quarterly earnings trigger fresh focus on UIE stock UIE (CPSE:UIE) is back on investor watch after its 19 August earnings release, which showed higher second quarter sales and net income, alongside sharply lower profit and earnings per share for the first half of 2026. See our latest analysis for UIE. The recent earnings update has arrived alongside a 12.15% 90 day share price return to DKK397.0 and a 38.58% 1 year total shareholder return. This suggests stronger momentum building around...

A week ago, H. Lundbeck A/S ( CPH:HLUN B ) came out with a strong set of second-quarter numbers that could potentially...

GN Store Nord (CPSE:GN) shares reacted to a busy set of updates after the company upgraded its 2026 adjusted EBITA margin guidance and confirmed progress on the planned sale of its hearing business. See our latest analysis for GN Store Nord. At a share price of DKK94.14, GN Store Nord has seen a 1 day share price return of 4.37%, while the 1 year total shareholder return is down 21.22%. This suggests that recent momentum contrasts with weaker long term performance as investors reassess the...

ISS (CPSE:ISS) drew investor attention after reporting half year 2026 results, reaffirming its full year earnings guidance and expanding its share buyback authorization. The update combined operational data with a clearer view of capital returns. See our latest analysis for ISS. The latest earnings update and larger buyback sit against a share price of DKK292.0, with a 90 day share price return of 10.19% and a year to date share price return of 35.44%. Over longer horizons, total shareholder...

Gubra stock has been on a tear in recent months, closing at DKK390.2 and sitting on a double digit gain over 30 and 90 days. Yet the fresh H1 2026 report tells a tougher story on the income statement, with revenue of DKK126.3m sitting beside a net loss of DKK110.0m. The real headline is not this half year loss. It is the tension between heavy investment in obesity and peptide drug discovery on one side and a valuation that already prices in a lot of future success on the other. Short term...

SP Group stock has barely moved over the past month, yet the latest earnings land with far more force than the share price suggests. You are looking at a company trading on a P/E of 16.8x while delivering record first half 2026 results and a trailing net margin of 9.7%. The real story sits beyond today’s tick-by-tick moves. Revenue is running close to DKK 3.4b on a trailing twelve month basis, and earnings over the past year are reported up 32.4%. For long term holders, the question is how...

The quarterly results for Coloplast A/S ( CPH:COLO B ) were released last week, making it a good time to revisit its...

ALK-Abelló stock went into the earnings release under pressure, down roughly 20% over the past three months, yet the latest numbers tell a more resilient story. The company just posted trailing twelve month revenue of DKK 6,561m and earnings from continuing operations of DKK 1,280m, with a net profit margin near 19.5%. The key question for you now is whether that profit profile justifies a P/E of about 36x in a sector where many peers trade at far lower multiples. The rest of the earnings...

GN Store Nord stock came into this earnings print under pressure, down about 12% over the past week and weaker over the past quarter as well. The headline from Q2 is not a growth story. The group booked a loss from continuing operations and reported basic earnings per share of DKK 1.56 in the red, even though revenue from continuing operations reached DKK 2,171m. The key issue for investors is the balance sheet and valuation strain. Net interest bearing debt of DKK 9.6b remains heavy, while...

Vestas Wind Systems (CPSE:VWS) drew investor attention after reporting second quarter 2026 earnings, with higher sales and net income than a year earlier, while also raising EBIT margin guidance for the full year. See our latest analysis for Vestas Wind Systems. The earnings release and raised margin outlook appear to be contributing to building momentum in Vestas Wind Systems, with a 30 day share price return of 15.19% and a 1 year total shareholder return of 56.28% from a lower base, even...

Coloplast stock closed at DKK441.8 on Wednesday, only modestly higher over the past week and month, even after investors digested a quarter that quietly reset the earnings narrative. The headline is a sharp profit rebound. Q3 basic earnings per share landed at 6.49 DKK with net income of DKK1,462m and total revenue of DKK7,355m. The market still carries the scar of the recent one off loss that dragged the trailing net margin down to 7.5%. Today’s calm price action suggests investors are...

Royal Unibrew stock has slipped over the past week and month, yet today’s earnings story is less gloomy than the recent price action suggests. The brewer delivered Q2 revenue of DKK 4,426m and basic earnings per share of DKK 11.1, with trailing earnings putting the stock on a P/E of 13x, below both peers and the wider European beverage group. The real tension for investors is between that value label and a business still nudged by modest growth and higher debt, which sets the stage for a...

Why Genmab’s latest earnings and guidance update matters for investors Genmab (CPSE:GMAB) reported second quarter 2026 results with higher sales but lower net income compared with a year earlier. The company also raised full year revenue guidance, giving investors an updated view of expected performance. See our latest analysis for Genmab. Genmab’s latest earnings release and raised revenue guidance have coincided with strong recent momentum, with a 30 day share price return of 12.57% and a...

As the European markets navigate a landscape marked by resilient economic data and geopolitical uncertainties, investors are increasingly looking towards diverse opportunities. Penny stocks, though an older term, continue to attract attention due to their potential for growth at lower price points. These smaller or newer companies can offer unique investment opportunities when backed by strong financials and solid fundamentals.

A week ago, Zealand Pharma A/S ( CPH:ZEAL ) came out with a strong set of second-quarter numbers that could potentially...

Jeudan earnings event puts focus on revenue and profit trends Jeudan (CPSE:JDAN) reported second quarter 2026 results that showed higher sales but lower net income and earnings per share compared with the same period in 2025. Investors now have fresh numbers to reassess the stock. See our latest analysis for Jeudan. Jeudan's latest earnings update comes as the stock trades at DKK204.0, with a 1-day share price return of 0.99% and a year-to-date share price gain of 3.55%. Over the same period,...

As the European market navigates a landscape marked by resilient economic data and geopolitical uncertainties, the STOXX Europe 600 Index recently closed slightly lower, reflecting investor caution amid these mixed signals. Despite these challenges, opportunities may exist for investors seeking undervalued stocks that could benefit from current sector shifts and regional economic resilience. In this context, identifying stocks trading below their estimated value can be particularly appealing...

A.P. Møller - Mærsk A/S ( CPH:MAERSK B ) just released its quarterly report and things are looking bullish. A.P. Møller...

Shareholders of DFDS A/S ( CPH:DFDS ) will be pleased this week, given that the stock price is up 19% to kr.155...

It's been a good week for Solar A/S ( CPH:SOLAR B ) shareholders, because the company has just released its latest...

Aktieselskabet Schouw went into this report with the stock at DKK680 after a solid run over the past month, and the market is now weighing whether that optimism matches the earnings reality. The headline is clear: Q2 2026 delivered a sharp jump in profitability, with basic earnings per share at DKK14.18 and net income at DKK321m, both well ahead of Q1. In addition, management lifted full year revenue and EBITDA guidance for 2026, which puts the focus firmly on whether this improvement looks...

Global bond yields have pushed higher as inflation expectations adjust, which has pressured long term rates and made dependable cash flows more valuable in pricing models. When markets focus on macro swings, stocks with solid projected cash generation that also trade below fair value can get overlooked. This article highlights 3 stocks from the Undervalued Stocks Based On Cash Flows screener that stand out on this theme. The 3 stocks highlighted below are just a small sample, since the full...